Successful Re-administration of Osimertinib in Osimertinib-induced Interstitial Lung Disease with an Organizing Pneumonia Pattern: A Case Report and Literature Review

Osimertinib is the standard therapy for epidermal-growth-factor-receptor (EGFR)-mutant lung cancers. We herein report a case of osimertinib-induced interstitial lung disease (OsiILD) with an organizing pneumonia (OP) pattern and provide a literature-based review. Six months after osimertinib adminis...

Descripción completa

Detalles Bibliográficos
Autores principales: Itano, Junko, Higo, Hisao, Ohashi, Kadoaki, Makimoto, Go, Nishii, Kazuya, Hotta, Katsuyuki, Miyahara, Nobuaki, Maeda, Yoshinobu, Kiura, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118377/
https://www.ncbi.nlm.nih.gov/pubmed/31787696
http://dx.doi.org/10.2169/internalmedicine.3689-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118377/
https://www.ncbi.nlm.nih.gov/pubmed/31787696
http://dx.doi.org/10.2169/internalmedicine.3689-19

Ejemplares similares